GlassScriptPhysician profile
Jeanne M Franzone
NPI 1306163126
$15,337.06
in general payments reported to CMS, 2019-2025
9 companies · $591 in 2025
The $591 reported for 2025 was more than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.56 · 2020: $162 · 2021: $3,133 · 2022: $1,928 · 2023: $5,207 · 2024: $4,259 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,800 · Grant: $3,993 · Food and Beverage: $1,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,800.00 |
| Grant | $3,992.70 |
| Food and Beverage | $1,264.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthopediatrics Corp. | $8,262.43 | 2020-2025 | General Instruments |
| Medtronic, INC. | $3,992.70 | 2024 | Infuse Bone Graft |
| Orthopediatrics Canada Ulc | $1,636.96 | 2022 | |
| Medical Device Business Services, INC. | $512.06 | 2021-2025 | Trialtis, Velys, Expedium |
| Depuy Synthes Sales INC. | $345.40 | 2022-2025 | Expedium, Na |
| Smith+Nephew, INC. | $246.98 | 2019-2021 | |
| Stryker Corporation | $158.17 | 2023-2024 | N/A, Monterey Al, Bio Dbm |
| Ultragenyx Pharmaceutical INC. | $144.82 | 2024-2025 | |
| Orthofix Medical, INC. | $37.54 | 2025 | Fitbone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeanne Franzone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.